VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
KVUE
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
KVUEKenvue Inc.
$17.20$33.0B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
  1. Home
  2. Financial Ratios

  1. Home
  2. Stocks
  3. KVUE
  4. Financial Ratios

Kenvue Inc. (KVUE) Financial Ratios

Latest Ratios: P/E Ratio 22.6x · EV/EBITDA 12.4x · ROE 14.4%. (2020–2025 historical series)

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly

KVUE Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Market Cap$33.0B$33.1B$41.4B$41.2B———
Enterprise Value$40.5B$40.5B$49.1B$48.3B———
P/E Ratio →22.6322.6239.8724.75———
P/S Ratio2.182.192.682.67———
P/B Ratio3.073.074.283.68———
P/FCF19.1819.2131.0115.28———
P/OCF15.0315.0523.4013.01———

P/E links to full P/E history page with 30-year chart

KVUE EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
EV / Revenue—2.683.173.13———
EV / EBITDA12.4212.4319.9215.38———
EV / EBIT14.9717.0526.5718.95———
EV / FCF—23.5436.7417.89———

KVUE Profitability

Margins and return-on-capital ratios measuring operating efficiency

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Gross Margin58.1%58.1%58.0%56.0%55.4%55.9%54.2%
Operating Margin17.9%17.9%11.9%16.3%17.9%19.4%-6.8%
Net Profit Margin9.7%9.7%6.7%10.8%13.8%13.8%-6.1%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
ROE14.4%14.4%9.9%10.7%10.2%10.7%-4.8%
ROA5.6%5.6%3.9%6.0%7.5%7.3%-3.0%
ROIC11.4%11.4%7.8%8.2%8.4%11.7%-4.1%
ROCE13.2%13.2%8.7%11.0%11.3%12.8%-4.5%

KVUE Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Debt / Equity0.790.790.900.750.450.01—
Debt / EBITDA2.612.613.542.682.730.04—
Net Debt / Equity—0.690.790.630.39-0.03-0.03
Net Debt / EBITDA2.292.293.112.242.35-0.17—
Debt / FCF—4.335.732.613.63-15.67-0.20
Interest Coverage6.276.274.287.12———

KVUE Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Current Ratio0.960.960.961.121.501.220.61
Quick Ratio0.680.680.690.780.930.800.39
Cash Ratio0.180.180.190.250.310.180.08
Asset Turnover—0.560.600.550.550.540.50
Inventory Turnover3.803.804.083.672.993.903.93
Days Sales Outstanding—67.9162.8062.3956.0856.5253.74

KVUE Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Dividend Yield4.8%4.8%3.7%35.3%———
Payout Ratio107.6%107.6%150.7%874.6%———

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Earnings Yield4.4%4.4%2.5%4.0%———
FCF Yield5.2%5.2%3.2%6.5%———
Buyback Yield0.6%0.6%0.6%0.0%———
Total Shareholder Yield5.4%5.4%4.3%35.3%———
Shares Outstanding—$1.9B$1.9B$1.9B$1.9B$1.9B$1.9B

Key Metrics

Growth RegimeMixed
ProfitabilityStable
Balance SheetAdequate
Cash FlowStable
Top Statement Risk

Skin Health volume pressure

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Margin Recovery Masks Underlying Pressures

Operating margin expanded from 3.9% in Q2 2024 to 17.7% in Q2 2026, per reported figures, yet gross margin dipped to 58.2%, suggesting cost discipline is driving recovery rather than pricing power.

The operating margin recovery is largely attributable to the fading of separation-related costs and improved SG&A leverage, as gross margin has remained range-bound near 58-59%. However, the recent dip in gross margin from 59.1% in Q3 2025 to 58.2% in Q2 2026 may indicate input cost pressures or promotional activity. Net margin of 11.5% in Q2 2026 remains below the 12.1% seen in Q1 2026, reflecting ongoing volatility in non-operating items. Investors should monitor whether the operating margin can sustain above 17% as the company fully absorbs standalone costs.

Return on Capital Remains Subdued

ROIC has hovered between 2.0% and 3.5% over the past ten quarters, per company filings, well below the cost of capital, indicating limited value creation from invested capital.

Despite margin recovery, ROIC remains low, reflecting a high capital base driven by $9.3B in goodwill and intangibles from the spin-off. ROE has also been weak, ranging from 0.6% to 4.4%, with the Q2 2024 trough of 0.6% coinciding with separation costs. The asset turnover of 0.14-0.15 is stable but low, typical for consumer staples, yet the returns are insufficient to cover the cost of capital. This suggests that the company is not yet compounding returns, and any improvement will likely require either margin expansion or a reduction in the capital base through buybacks or impairments.

Working Capital Efficiency Shows Modest Gains

Cash conversion cycle improved from 37 days in Q4 2024 to 20 days in Q2 2026, per reported data, driven by a reduction in days inventory outstanding from 100 to 93.

The improvement in CCC is primarily due to better inventory management, as DIO fell from 106 days in Q3 2025 to 93 days in Q2 2026, while DSO remained stable near 67 days. DPO has been consistently high, around 140 days, indicating strong supplier leverage, though this may reflect extended payment terms that could strain supplier relationships. The quick ratio of 0.71 remains low, but the negative working capital position is common in consumer staples with high DPO. The efficiency gains are modest and may not be sustainable if inventory levels need to be rebuilt to support growth.

Leverage Elevated but Coverage Improving

Debt-to-EBITDA has declined from 29.17 in Q2 2024 to 10.05 in Q2 2026, per financial statements, while interest coverage improved from 1.61 to 7.64, indicating reduced refinancing risk.

The dramatic improvement in D/EBITDA reflects both EBITDA growth and debt reduction, though the ratio remains high relative to peers like PG (0.63) and CHD (0.55). Interest coverage of 7.64 is now comfortable, but the absolute debt level of $8.5B is substantial for a company with $10.6B in equity. The D/E ratio of 0.80 is manageable, but the company's ability to deleverage further will depend on sustained FCF generation. The cessation of buybacks and a dividend payout ratio exceeding 100% of net income suggest that cash is being prioritized for debt reduction, which is prudent but limits shareholder returns.

Thin Liquidity Buffer Persists

Current ratio has remained near 1.0 over the past ten quarters, with cash flat at $1.1B, per balance sheet data, providing a minimal cushion against short-term obligations.

The current ratio of 1.01 in Q2 2026 is barely above 1.0, and the quick ratio of 0.71 indicates heavy reliance on inventory to meet short-term liabilities. This thin liquidity position is typical for consumer staples with strong supplier financing, but it leaves little room for unexpected cash outflows. The company's ability to weather a demand shock would depend on its access to credit markets, which is not directly observable from the data. Investors should monitor whether the company can maintain its dividend while continuing to deleverage, as the payout ratio already exceeds 100% of net income.

Misapplied Metric: EV/EBITDA

EV/EBITDA of 13.59 appears reasonable, but it understates leverage because EBITDA does not capture the high cash interest costs and the company's thin liquidity, per reported figures.

For a company with significant debt and a low current ratio, EV/EBITDA can be misleading because it ignores the capital structure's risk. A more appropriate metric would be EV/EBIT or EV/EBITDAR, which accounts for the high depreciation and amortization from the spin-off's step-up in asset values. Additionally, the company's FCF yield of 4.7% (based on P/FCF of 21.41) is more informative, as it reflects actual cash generation after capex. Investors should also consider the dividend payout ratio, which exceeds 100% of net income, indicating that the dividend may not be fully covered by earnings.

Download Financial Ratios Data

Includes 30+ ratios · 6 years · Updated daily

Consensus & Technical Research Suite
Open KVUE Terminal

KVUE Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

KVUE — Frequently Asked Questions

Quick answers to the most common questions about buying KVUE stock.

What is Kenvue Inc.'s P/E ratio?

Kenvue Inc.'s current P/E ratio is 22.6x. The historical average is 29.1x. This places it at the 33th percentile of its historical range.

What is Kenvue Inc.'s EV/EBITDA?

Kenvue Inc.'s current EV/EBITDA is 12.4x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 15.9x.

What is Kenvue Inc.'s ROE?

Kenvue Inc.'s return on equity (ROE) is 14.4%. The historical average is 8.5%.

Is KVUE stock overvalued?

Based on historical data, Kenvue Inc. is trading at a P/E of 22.6x. This is at the 33th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.

What is Kenvue Inc.'s dividend yield?

Kenvue Inc.'s current dividend yield is 4.78% with a payout ratio of 107.6%.

What are Kenvue Inc.'s profit margins?

Kenvue Inc. has 58.1% gross margin and 17.9% operating margin. Operating margin between 10-20% is typical for established companies.

How much debt does Kenvue Inc. have?

Kenvue Inc.'s Debt/EBITDA ratio is 2.6x, indicating moderate leverage. A ratio between 2-4x is manageable but warrants monitoring.